Stock listing

LSE:0LB2 Supernus Pharmaceuticals, Inc. Share Price

UK listing (LSE) of Supernus Pharmaceuticals, Inc. · home listing NASDAQ:SUPN

Follow Supernus Pharmaceuticals, Inc. into a list and get an email when it puts out news.

Share price · LSE:0LB2

$40.48 USD -0.08 (-0.2%)

Close on Oct 27, 2026

Day range
$40.48 – $40.48 USDOct 27, 2026
Volume
1 sharesOct 27, 2026
Supernus Pharmaceuticals, Inc. logo

Prices by listing

ListingLastChangeVolumeOpenHighLowPrevious closePrice from
NASDAQ:SUPN · Home$41.92 USD+0.08 (+0.2%)2,818,869$42.07$43.72$39.53$41.84Close on Oct 30, 2026
LSE:0LB2$40.48 USD-0.08 (-0.2%)1$40.48$40.48$40.48$40.56Close on Oct 27, 2026
Frankfurt:S49€37.20 EUR+0.80 (+2.2%)—€37.20€37.20€37.20€36.40Close on Oct 30, 2026
Ticker
LSE:0LB2
Asset type
Stock
Exchange
LSE
Currency
USD

What changed lately

Calls

Replays

  • Supernus Pharmaceuticals (NASDAQ:SUPN) Q3 2026 Earnings Call

    Thu, Oct 29, 2026 · 4:30 PM ET

    Watch Transcript
  • Supernus Pharmaceuticals (NASDAQ:SUPN) Q2 2026 Earnings Call

    Tue, Aug 04, 2026 · 4:30 PM ET

    Watch Transcript
  • Supernus Pharmaceuticals (NASDAQ:SUPN) Q1 2026 Earnings Call

    Tue, May 05, 2026 · 4:30 PM ET

    Watch Transcript

Latest news

All Supernus Pharmaceuticals, Inc. news

Decks

Supernus Pharmaceuticals, Inc. on 6ix

News releases
22 in the last 12 months · 161 in all · newest Nov 2, 2026 · oldest 2019
Calls
25 calls with a replay · 25 with a transcript · latest Oct 29, 2026
Decks
17 decks · latest Oct 29, 2026

Where Supernus Pharmaceuticals, Inc. is listed

ListingExchangeCountryCurrency
NASDAQ:SUPN · Home listingNASDAQUnited StatesUSD
Lang & Schwarz:A1JX3ULang & SchwarzGermanyEUR
LS Exchange:A1JX3ULS ExchangeGermanyEUR
gettex:S49gettexGermanyEUR
BOATS:SUPNBOATSUnited StatesUSD
LSE:0LB2 · This pageLSEUnited KingdomUSD
Frankfurt:S49FrankfurtGermanyEUR
BX Swiss:S49BX SwissSwitzerlandCHF
Dusseldorf:S49DusseldorfGermanyEUR
Munich:S49MunichGermanyEUR
Stuttgart:S49StuttgartGermanyEUR
Tradegate:S49TradegateGermanyEUR

Log in to ask 6ix AI your own questions about Supernus Pharmaceuticals, Inc.